Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Financial Flexibility Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Financial Flexibility Index of 1.50x as of December 2024. Free cash flow of CN¥149.55 Million (operating CF CN¥116.38 Million minus capex CN¥33.16 Million) represents 2% of total liabilities (CN¥99.57 Million). Check 301033 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. See Medprin Regenerative Medical Technologie short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Medprin Regenerative Medical Technologies Co. Ltd.. For the full company profile including market capitalisation, see market cap of Medprin Regenerative Medical Technologie.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.50x | CN¥149.55 Million | CN¥116.38 Million | CN¥99.57 Million | ▲ +53.6% |
| 2023 | 0.98x | CN¥147.77 Million | CN¥107.69 Million | CN¥151.11 Million | ▼ -24.5% |
| 2022 | 1.29x | CN¥184.27 Million | CN¥48.31 Million | CN¥142.34 Million | ▲ +0.9% |
| 2021 | 1.28x | CN¥219.22 Million | CN¥66.51 Million | CN¥170.92 Million | ▲ +57.4% |
| 2020 | 0.81x | CN¥95.55 Million | CN¥33.91 Million | CN¥117.26 Million | ▼ -55.3% |
| 2019 | 1.82x | CN¥67.98 Million | CN¥31.27 Million | CN¥37.27 Million | — |